Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.

<h4>Aims</h4>It has been reported that cardiac ankyrin repeat protein is associated with heart development and diseases. This study is aimed to investigate the role of CARP in heart hypertrophy in vivo.<h4>Methods and results</h4>We generated a cardiac-specific CARP-overexpre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yao Song, Jialin Xu, Yanfeng Li, Chunshi Jia, Xiaowei Ma, Lei Zhang, Xiaojie Xie, Yong Zhang, Xiang Gao, Youyi Zhang, Dahai Zhu
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1f37027918784749a6e1a03c0d897066
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1f37027918784749a6e1a03c0d897066
record_format dspace
spelling oai:doaj.org-article:1f37027918784749a6e1a03c0d8970662021-11-18T08:06:20ZCardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.1932-620310.1371/journal.pone.0050436https://doaj.org/article/1f37027918784749a6e1a03c0d8970662012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23227174/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Aims</h4>It has been reported that cardiac ankyrin repeat protein is associated with heart development and diseases. This study is aimed to investigate the role of CARP in heart hypertrophy in vivo.<h4>Methods and results</h4>We generated a cardiac-specific CARP-overexpressing transgenic mouse. Although such animals did not display any overt physiological abnormality, they developed less cardiac hypertrophy in response to pressure overload than did wildtype mice, as indicated by heart weight/body weight ratios, echocardiographic and histological analyses, and expression of hypertrophic markers. These mice also exhibited less cardiac hypertrophy after infusion of isoproterenol. To gain a molecular insight into how CARP attenuated heart hypertrophy, we examined expression of the mitogen-activated protein kinase cascade and found that the concentrations of phosphorylated ERK1/2 and MEK were markedly reduced in the hearts of transgenic mice subjected to pressure overload. In addition, the expressions of TGF-β and phosphorylated Smad3 were significantly downregulated in the hearts of CARP Tg mice in response to pressure overload. Furthermore, addition of human TGF-β1 could reverse the inhibitory effect of CARP on the hypertrophic response induced by phenylephrine in cardiomyocytes. It was also evidenced that the inhibitory effect of CARP on cardiac hypertrophy was not attributed to apoptosis.<h4>Conclusion</h4>CARP attenuates cardiac hypertrophy, in which the ERK and TGF-β pathways may be involved. Our findings highlight the significance of CARP as an anti-hypertrophic factor in therapy of cardiac hypertrophy.Yao SongJialin XuYanfeng LiChunshi JiaXiaowei MaLei ZhangXiaojie XieYong ZhangXiang GaoYouyi ZhangDahai ZhuPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 12, p e50436 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yao Song
Jialin Xu
Yanfeng Li
Chunshi Jia
Xiaowei Ma
Lei Zhang
Xiaojie Xie
Yong Zhang
Xiang Gao
Youyi Zhang
Dahai Zhu
Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.
description <h4>Aims</h4>It has been reported that cardiac ankyrin repeat protein is associated with heart development and diseases. This study is aimed to investigate the role of CARP in heart hypertrophy in vivo.<h4>Methods and results</h4>We generated a cardiac-specific CARP-overexpressing transgenic mouse. Although such animals did not display any overt physiological abnormality, they developed less cardiac hypertrophy in response to pressure overload than did wildtype mice, as indicated by heart weight/body weight ratios, echocardiographic and histological analyses, and expression of hypertrophic markers. These mice also exhibited less cardiac hypertrophy after infusion of isoproterenol. To gain a molecular insight into how CARP attenuated heart hypertrophy, we examined expression of the mitogen-activated protein kinase cascade and found that the concentrations of phosphorylated ERK1/2 and MEK were markedly reduced in the hearts of transgenic mice subjected to pressure overload. In addition, the expressions of TGF-β and phosphorylated Smad3 were significantly downregulated in the hearts of CARP Tg mice in response to pressure overload. Furthermore, addition of human TGF-β1 could reverse the inhibitory effect of CARP on the hypertrophic response induced by phenylephrine in cardiomyocytes. It was also evidenced that the inhibitory effect of CARP on cardiac hypertrophy was not attributed to apoptosis.<h4>Conclusion</h4>CARP attenuates cardiac hypertrophy, in which the ERK and TGF-β pathways may be involved. Our findings highlight the significance of CARP as an anti-hypertrophic factor in therapy of cardiac hypertrophy.
format article
author Yao Song
Jialin Xu
Yanfeng Li
Chunshi Jia
Xiaowei Ma
Lei Zhang
Xiaojie Xie
Yong Zhang
Xiang Gao
Youyi Zhang
Dahai Zhu
author_facet Yao Song
Jialin Xu
Yanfeng Li
Chunshi Jia
Xiaowei Ma
Lei Zhang
Xiaojie Xie
Yong Zhang
Xiang Gao
Youyi Zhang
Dahai Zhu
author_sort Yao Song
title Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.
title_short Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.
title_full Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.
title_fullStr Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.
title_full_unstemmed Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.
title_sort cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of erk1/2 and tgf-β signaling pathways.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/1f37027918784749a6e1a03c0d897066
work_keys_str_mv AT yaosong cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT jialinxu cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT yanfengli cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT chunshijia cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT xiaoweima cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT leizhang cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT xiaojiexie cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT yongzhang cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT xianggao cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT youyizhang cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
AT dahaizhu cardiacankyrinrepeatproteinattenuatescardiachypertrophybyinhibitionoferk12andtgfbsignalingpathways
_version_ 1718422214986956800